-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Upgrades Agilon Health to Neutral, Raises Price Target to $115

Benzinga·08/11/2026 12:22:28
Listen to the news
Citigroup analyst Daniel Grosslight upgrades Agilon Health (NYSE:AGL) from Sell to Neutral and raises the price target from $105 to $115.